Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026)
Zai Lab's (ZLAB) quarterly Other Non-Current Assets came in at $1.1 million in Q1 2026, down 55.92% year-on-year from $2.5 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $1.1 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.1 million, down 55.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 55.92% YoY), and the FY2025 annual result was $1.1 million, changed 0.18% from the prior year.
- Other Non-Current Assets came in at $1.1 million for Q1 2026 at Zai Lab, roughly flat from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q2 2025 to a low of $800000.0 in Q4 2022.
- The 5-year median for Other Non-Current Assets is $1.1 million (2024), against an average of $1.3 million.
- Across the five-year window, Other Non-Current Assets jumped 132.89% in 2025 and tumbled 55.92% in 2026, its largest moves.
- Zai Lab's Other Non-Current Assets stood at $800000.0 in 2022, then soared by 39.12% to $1.1 million in 2023, then grew by 0.09% to $1.1 million in 2024, then rose by 0.18% to $1.1 million in 2025, then grew by 0.09% to $1.1 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 975,000.00 |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 803,000.00 |
| Jun 30, 2022 | 803,000.00 |
| Mar 31, 2022 | 803,000.00 |
| Dec 31, 2021 | 803,000.00 |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 743,000.00 |